Medivir AB (FRA:MVR0)
€ 0.211 -0.017 (-7.46%) Market Cap: 27.91 Mil Enterprise Value: 14.54 Mil PE Ratio: 0 PB Ratio: 1.77 GF Score: 46/100

Q3 2019 Medivir AB Earnings Call Transcript

Nov 27, 2019 / 01:00PM GMT
Release Date Price: €1.4 (-0.99%)
Operator

Ladies and gentlemen, welcome to the Medivir AB Q3 Report 2019. (Operator Instructions)

Today, I'm pleased to present Mr. Uli Hacksell, CEO; Mr. Magnus Christensen, CFO; Ms. Linda Basse, Chief Medical Officer; and Mrs. Christina Herder, COO.

Speakers, please begin.

Uli Hacksell;publ;CEO
Medivir AB;President & Director

()- -

Thank you so much, and good afternoon. I would like to start this by asking you to read Slide #2, which really reflects the problem with forward-looking statements, so please read that carefully.

Let's move to Slide 3, which is related to the financial summary. Please, Magnus.

Magnus Christensen;publ;CFO
Medivir AB

()-

Thank you, Uli. And yes, please see Slide 3, where you can see the financial summary for quarter 3 and accumulated quarter 1 to quarter 3. As you can see, the turnover for quarter 3 amounts around SEK 2 million, which is lower than last year and relates mainly to lower royalty

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot